Disruptive Technology Channel Healthcare Technology ETF HTEC Red Hot to Start 2025 By Nick Peters-GoldenJanuary 29, 2025
Leveraged & Inverse Channel There Could Be Value in Healthcare Stocks Ahead of 2025 By Ben HernandezDecember 13, 2024
ETF Building Blocks Channel Biotech Looms as a Way to Beat the Market By Nick Peters-GoldenDecember 2, 2024
ETF Building Blocks Channel Steady Rate Cuts Feed Surging Biotech ETF SBIO By Nick Peters-GoldenNovember 13, 2024
ETF Building Blocks Channel How Election Results Could Impact Biotech ETFs By Todd ShriberNovember 12, 2024
ETF Building Blocks Channel Biotech ETF SBIO Laps Tech Rivals Over 1 Year By Nick Peters-GoldenOctober 22, 2024
ETF Building Blocks Channel Biotech Stocks Are Perking Up. This ETF Is Responding By Todd ShriberSeptember 4, 2024
ETF Building Blocks Channel Biotech ETF SBIO Rides Strong Momentum Into Rate Cuts By Nick Peters-GoldenAugust 29, 2024
ETF Building Blocks Channel Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO By Nick Peters-GoldenAugust 19, 2024
ETF Building Blocks Channel Returns Spiking for This Rate-Sensitive ETF By Nick Peters-GoldenJuly 19, 2024
Leveraged & Inverse Channel Early IPO Activity Could Spell Bullishness for Biotech Industry By Ben HernandezJanuary 26, 2024
ETF Building Blocks Channel Biotech ETF SBIO’s Momentum Strong to End 2023 By Nick Peters-GoldenDecember 28, 2023
ETF Building Blocks Channel Play US Gene Treatment Approval in SBIO By Nick Peters-GoldenDecember 7, 2023
Leveraged & Inverse Channel 3 Trades to Consider Amid Early Summer Rally By Ben HernandezJuly 6, 2023
Beyond Basic Beta Channel Bull vs. Bear: How Healthy Are Biotech ETFs? By The VettaFi WritersMay 10, 2023
Disruptive Technology Channel Rising Biotech ETF HTEC Signaling a Buy By Nick Peters-GoldenMay 3, 2023
ETF Building Blocks Channel ALPS’ Biotech ETF SBIO Week’s Top Performer By Nick Peters-GoldenApril 24, 2023
